Paul Friedman
-
Former Sanofi Executive Named CEO of Conshohocken-based Madrigal Pharmaceuticals
Conshohocken biopharmaceutical company Madrigal Pharmaceuticals has named Bill Sibold as the new CEO taking over from Dr. Paul Friedman. He…
-
Conshohocken-based Madrigal Pharmaceuticals’ Shares Skyrocket Following Liver Disease Clinical Trial
Conshohocken-based Madrigal Pharmaceuticals saw its shares leap in value after the company reported additional positive late-stage clinical trial data for…
-
Tiny Madrigal’s stock is soaring as it advances an experimental drug targeting NASH
Madrigal Pharmaceuticals can’t stay hidden in West Conshohocken much longer. The 7-year-old company has experienced a rapid rise in its…
-
Stock price surges for small West Conshohcken drug company
Madrigal Pharmaceuticals, West Conshohocken, has experienced a rapid rise in its stock price and market capitalization, which at the start of…
-
Fort Washington’s Madrigal Pharmaceuticals Completes Merger with Synta, Creates Leader in Field
Fort Washington’s Madrigal Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutic candidates for the…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
